Compare SHASUN PHARMA with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA TORRENT PHARMA SHASUN PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 123.9 55.1 225.0% View Chart
P/BV x 8.5 6.6 129.3% View Chart
Dividend Yield % 0.2 0.8 30.0%  

Financials

 SHASUN PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TORRENT PHARMA
Mar-18
SHASUN PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs941,550 6.1%   
Low Rs461,144 4.0%   
Sales per share (Unadj.) Rs214.2354.7 60.4%  
Earnings per share (Unadj.) Rs5.340.1 13.3%  
Cash flow per share (Unadj.) Rs15.864.2 24.6%  
Dividends per share (Unadj.) Rs1.0014.00 7.1%  
Dividend yield (eoy) %1.41.0 137.6%  
Book value per share (Unadj.) Rs53.3273.1 19.5%  
Shares outstanding (eoy) m56.62169.22 33.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.8 8.6%   
Avg P/E ratio x13.133.6 39.0%  
P/CF ratio (eoy) x4.421.0 21.1%  
Price / Book Value ratio x1.34.9 26.6%  
Dividend payout %18.734.9 53.6%   
Avg Mkt Cap Rs m3,958227,897 1.7%   
No. of employees `000NA14.7 0.0%   
Total wages/salary Rs m2,16411,353 19.1%   
Avg. sales/employee Rs ThNM4,083.0-  
Avg. wages/employee Rs ThNM772.3-  
Avg. net profit/employee Rs ThNM461.3-  
INCOME DATA
Net Sales Rs m12,12760,021 20.2%  
Other income Rs m2292,988 7.7%   
Total revenues Rs m12,35663,009 19.6%   
Gross profit Rs m1,00913,493 7.5%  
Depreciation Rs m5944,086 14.5%   
Interest Rs m4153,085 13.5%   
Profit before tax Rs m2309,310 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-732,529 -2.9%   
Profit after tax Rs m3026,781 4.5%  
Gross profit margin %8.322.5 37.0%  
Effective tax rate %-31.727.2 -116.6%   
Net profit margin %2.511.3 22.1%  
BALANCE SHEET DATA
Current assets Rs m6,88452,623 13.1%   
Current liabilities Rs m8,45652,022 16.3%   
Net working cap to sales %-13.01.0 -1,293.2%  
Current ratio x0.81.0 80.5%  
Inventory Days Days62120 51.5%  
Debtors Days Days10876 141.1%  
Net fixed assets Rs m4,97085,016 5.8%   
Share capital Rs m113846 13.4%   
"Free" reserves Rs m2,87545,376 6.3%   
Net worth Rs m3,02046,222 6.5%   
Long term debt Rs m1,81741,115 4.4%   
Total assets Rs m13,347142,432 9.4%  
Interest coverage x1.64.0 38.7%   
Debt to equity ratio x0.60.9 67.6%  
Sales to assets ratio x0.90.4 215.6%   
Return on assets %5.46.9 77.6%  
Return on equity %10.014.7 68.2%  
Return on capital %13.314.2 93.9%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84314,580 40.1%   
Fx outflow Rs m2,1733,600 60.4%   
Net fx Rs m3,66910,980 33.4%   
CASH FLOW
From Operations Rs m3988,942 4.4%  
From Investments Rs m-1,635-47,070 3.5%  
From Financial Activity Rs m1,30934,174 3.8%  
Net Cashflow Rs m71-3,655 -1.9%  

Share Holding

Indian Promoters % 39.2 71.5 54.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 7.0 51.3%  
FIIs % 17.6 12.6 139.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 8.8 450.0%  
Shareholders   20,750 26,511 78.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  FDC LTD.  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS